[[9, 36, [[4, 486, "Table 1. Furan Replacement SAR"]]], [133, 150, [[296, 322, "R2"]]], [244, 310, [[26, 156, "Compound"], [259, 296, "R2"], [419, 544, "IL-1 IC50 (M)c"], [620, 704, "cLogP cLogD"], [758, 831, "LLEb"]]], [331, 402, [[78, 99, "1"], [197, 238, "HO"], [404, 560, "0.029  0.015 (n=50)"], [640, 685, "2.9 0.5"], [776, 821, "7.0"]]], [440, 500, [[76, 102, "2"], [452, 512, "0.44"], [642, 687, "2.6 0.7"], [776, 817, "5.7"]]], [538, 609, [[80, 99, "3"], [454, 512, "1.79"], [636, 688, "3.3 1.2"], [776, 817, "4.5"]]], [654, 716, [[82, 99, "4"], [452, 510, "1.33"], [642, 687, "2.7 0.5"], [776, 821, "5.4"]]], [761, 821, [[78, 104, "5"], [454, 510, "1.08"], [642, 687, "2.2 0.3"], [776, 817, "5.7"]]], [868, 930, [[80, 99, "6"], [454, 512, "1.54"], [642, 687, "2.1 0.4"], [776, 821, "5.4"]]], [962, 973, [[257, 270, "N"]]], [977, 1037, [[74, 103, "1"], [452, 512, "0.96"], [640, 685, "1.6 0.1"], [776, 821, "5.9"]]], [1084, 1141, [[76, 104, "8"], [452, 512, "3.66"], [640, 685, "2.6 0.6"], [776, 821, "4.8"]]], [1191, 1253, [[76, 102, "9"], [452, 510, "0.43"], [642, 687, "2.8 0.7"], [774, 819, "5.7"]]], [1296, 1362, [[71, 108, "10"], [256, 284, "N."], [452, 510, "2.31"], [640, 683, "2.1 0"], [776, 821, "5.6"]]], [1409, 1473, [[71, 106, "11"], [452, 510, "2.55"], [640, 689, "2.4 0.4"], [774, 819, "5.2"]]], [1518, 1577, [[73, 108, "12"], [452, 512, "0.34"], [642, 683, "2.1 0.3"], [776, 821, "6.2"]]], [1622, 1686, [[71, 110, "13"], [454, 508, "0.21"], [637, 689, "1.8 0.4"], [776, 817, "6.3"]]], [1729, 1761, [[2, 854, "'Inhibition of the NLRP3 inflammasome pathway was assessed by"]]], [1763, 1872, [[0, 858, "quantifying IL-1 release from lipopolysaccharide (LPS) + nigericin. stimulated hPBMCs (n = 1 for all compounds except compound 1) which is reported as the geometric mean  SD). LLE was calculated"]]], [1971, 2001, [[2, 856, "potency was also observed in a number of ortho substituted"]]]]